Dr. Christos Coutifaris

Dr. Coutifaris was a resident at the Hospital of the University of Pennsylvania. He is an Attending Physician at the Hospital of the University of Pennsylvania and a Director of the Fellowship Program in Reproductive Endocrinology and Infertility Approved by the American Board of Obstetrics and Gynecology and ACGME at Penn Medicine. He is a Diversity Search Advisor and Education Officer of Obstetrics and Gynecology at Perelman School of Medicine, University of Pennsylvania. He is also a Director, of the Endocrine Laboratory, CAP Accredited, Division of Reproductive Endocrinology, Infertility, Obstetrics and Gynecology at Penn Medicine.

Dr. Christos was recognized annually in Philadelphia Magazine's Top Docs issue from 2004 through 2012, recognized by America's Top Doctors in 2007, 2008, 2010, and 2012, and recognized by Best Doctors in America from 2003 to 2018. He is Chair of the Department of Ob/Gyn Committee on Appointments and Promotions, OBGYN, UPHS, and Vice Chair of Faculty Development, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania. He is a Member of the Center for Research in Reproduction and Women's Health and a Member Of the Cancer Center at the University of Pennsylvania.

Dr. Coutifaris is a member of the American College of Obstetricians and Gynecologists, Fellow, National, the American Gynecological and Obstetrical Society (AGOS), National, the American Society for Reproductive Medicine, National, the Hellenic Medical Society of Greater Philadelphia, Local, the NIH, EMNR Special Emphasis Panel, National, the NIH, NICHD Special Emphasis Panel, National, the NIH, Oversight Committee for the NICHD Intramural Program in Perinatal Research and Obstetrics (PPRO), National, the Philadelphia Area Reproductive Endocrinology Society, Local, the Philadelphia Obstetrical Society, Local, the Society for Reproductive Endocrinology and Infertility, National, the Society for the Study of Reproduction, National, and the Society of Assisted Reproductive Technologies, National.